Latest filings (excl ownership)
8-K
Other Events
25 Apr 24
S-1/A
IPO registration (amended)
5 Apr 24
S-1
IPO registration
22 Mar 24
10-Q
2024 Q3
Quarterly report
14 Feb 24
8-K
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
14 Feb 24
8-K/A
Departure of Directors or Certain Officers
22 Dec 23
8-K
Departure of Directors or Certain Officers
27 Nov 23
10-Q
2024 Q2
Quarterly report
14 Nov 23
8-K
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
14 Nov 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
8-K
Aethlon Announces Reverse Stock Split
4 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
18 Sep 23
10-Q
2023 Q1
Quarterly report
10 Aug 23
8-K
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
10 Aug 23
ARS
2023 FY
Annual report to shareholders
27 Jul 23
DEF 14A
Definitive proxy
27 Jul 23
PRE 14A
Preliminary proxy
17 Jul 23
8-K
Departure of Directors or Certain Officers
6 Jul 23
10-K
2023 FY
Annual report
28 Jun 23
8-K
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
28 Jun 23
8-K
Other Events
25 Apr 23
10-Q
2023 Q3
Quarterly report
13 Feb 23
8-K
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update
13 Feb 23
10-Q
2022 Q2
Quarterly report
14 Nov 22
8-K
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update
14 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Oct 22
8-K
Other Events
29 Sep 22
424B5
Prospectus supplement for primary offering
29 Sep 22
8-K
Other Events
29 Sep 22
S-8
Registration of securities for employees
19 Sep 22
8-K
Departure of Directors or Certain Officers
19 Sep 22
10-Q
2023 Q1
Quarterly report
9 Aug 22
8-K
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update
9 Aug 22
424B5
Prospectus supplement for primary offering
3 Aug 22
DEF 14A
Definitive proxy
27 Jul 22
PRE 14A
Preliminary proxy
15 Jul 22
10-K
2022 FY
Annual report
28 Jun 22
8-K
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
28 Jun 22
8-K
Departure of Directors or Certain Officers
28 Mar 22
8-K
Entry into a Material Definitive Agreement
24 Mar 22
Latest ownership filings
4
EDWARD G BROENNIMAN
17 Apr 24
4
Angela Rossetti
17 Apr 24
4
Chetan Shah
17 Apr 24
4
Nicolas Gikakis
17 Apr 24
4
Nicolas Gikakis
1 Apr 24
4
EDWARD G BROENNIMAN
1 Apr 24
4
Chetan Shah
1 Apr 24
4
Nicolas Gikakis
2 Jan 24
4
EDWARD G BROENNIMAN
2 Jan 24
4
Chetan Shah
2 Jan 24
4
Chetan Shah
29 Sep 23
4
EDWARD G BROENNIMAN
29 Sep 23
4
Nicolas Gikakis
29 Sep 23
4
Nicolas Gikakis
6 Jul 23
3
Nicolas Gikakis
6 Jul 23
4
Chetan Shah
3 Jul 23
4
EDWARD G BROENNIMAN
3 Jul 23
4
EDWARD G BROENNIMAN
1 May 23
4
Angela Rossetti
1 May 23
4
Chetan Shah
1 May 23
4
Chetan Shah
31 Mar 23
4
EDWARD G BROENNIMAN
31 Mar 23
4
Lee D Arnold
2 Feb 23
3
Lee D Arnold
2 Feb 23
4
Chetan Shah
30 Dec 22
4
EDWARD G BROENNIMAN
30 Dec 22
4
EDWARD G BROENNIMAN
4 Oct 22
4
Chetan Shah
4 Oct 22
4
Angela Rossetti
16 Sep 22
4
EDWARD G BROENNIMAN
16 Sep 22
4
Chetan Shah
16 Sep 22
3
Angela Rossetti
1 Apr 22
4
SABRINA MARTUCCI JOHNSON
31 Mar 22
4
EDWARD G BROENNIMAN
31 Mar 22
4
Chetan Shah
31 Mar 22
4
JAMES B FRAKES
11 Feb 22
4
Guy F. Cipriani
11 Feb 22
4
STEVEN P LAROSA
11 Feb 22
4
CHARLES J FISHER JR
11 Feb 22
SC 13G/A
Empery Asset Management, LP
13 Jan 22